Literature DB >> 755642

Effects of R-28935 on sympathetic nervous activity in anesthetized cat.

D G Taylor, M J Antonaccio.   

Abstract

Intravenous administration of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-Et]-4-piperidyl)-2-benzimidazolinone (R-28935) (25--100 microgram/kg) produced a dose-related decrease in spontaneous electrical activity recorded in the splanchnic and renal nerves. Reductions in sympathetic nerve activity were paralleled by hypotension and bradycardia. R 28935-induced depressor responses were not affected by baroreceptor denervation, piperoxan, yohimbine or phentolamine. Results support the idea that R-28935 decreased resting blood pressure and heart rate through a reduction in central sympathetic outflow which does not involve alpha-adrenergic receptor activation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 755642     DOI: 10.3109/10641967809068598

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  2 in total

1.  The regional localization of R28935 in the cat brain as dependent on the route of administration.

Authors:  A J Loonen; W Soudijn; H H van Rooij; I V Wijngaarden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

2.  Interaction between prazosin and benzodioxan antihypertensives (R 28935 and R 29814); a competition for central alpha 1-adrenoceptors [proceedings].

Authors:  H Y Kwa; P B Timmermans; P A Van Zwieten
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.